1,5-diphenyl-pyrrolidin-2-one compounds as CB-1 ligands

Details for Australian Patent Application No. 2009238445 (hide)

Owner Eli Lilly and Company

Inventors Schaus, John Mehnert

Agent Spruson & Ferguson

Pub. Number AU-A-2009238445

PCT Pub. Number WO2009/131815

Priority 61/046,943 22.04.08 US

Filing date 2 April 2009

Wipo publication date 29 October 2009

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

30 September 2010 PCT application entered the National Phase

  PCT publication WO2009/131815 Priority application(s): WO2009/131815

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009238448-Multi-functional patient transfer device

2009238444-1,5-diphenyl-pyrrolidin-2-one compounds as CB-1 ligands